In addition, androgen receptor and androgen metabolic pathway genetic variation studies showed that Ser312-Asn polymorphism of the luteinizing hormone receptor was linked to an decreased relative risk of TGCT [24]. The gene discussed is AR; the disease is testicular germ cell tumor.